Dana CFO: $300M Buyback Since Eaton Deal, Vote Dec 7, One Approval Left
DAN sits 26% above its 52-week low of $18.955.
Summary
Ahead of the December 7 vote on the Eaton Mobility combination, Dana's CFO disclosed $300 million of buybacks since signing, roughly $75 million of first-year synergies on the way to $250 million, and only one small regulatory approval outstanding.
Key Events · M&A and Partnerships · DAN
-
CFO Updates Eaton Deal Economics
On the November 19 Barclays fireside chat, CFO Tim Kraus said the Eaton Mobility Reverse Morris Trust is down to one very small outstanding regulatory approval, with the Dana shareholder vote set for December 7.
-
$300M Buybacks Offset Deal Dilution
Dana has repurchased $300 million of stock since signing; the CFO said each dollar bought back effectively avoids about $2 of issuance because fewer shares go to Eaton holders.
-
Buyback Restriction Still Unresolved
The agreement bars buybacks for 24 months after closing, and Dana is negotiating with Eaton for relief, which the CFO expects to resolve before closing.
-
Synergy Phasing Laid Out
About $75 million of the $250 million cost synergies are expected in year one, $200 million cumulative by year two, and full run-rate after 2028, at roughly $200 million of cost to achieve.
Analysis · DAN · Manufacturing
Ahead of the December 7 shareholder vote on the Eaton Mobility Reverse Morris Trust, Dana's CFO used a Barclays fireside chat to put numbers on the pending deal. The most consequential new fact: Dana has already bought back $300 million of stock since signing, and each dollar spent avoids roughly $2 of shares it would otherwise issue to Eaton holders — a real offset to deal dilution. Against that, the contract bars buybacks for 24 months after closing and no Eaton agreement has been reached yet, so the program's future is unresolved. The CFO also laid out 2027 economics: about $75 million of the $250 million synergies land in year one, $200 million by year two, full run-rate after 2028, against roughly $200 million of cost to achieve, with purchase accounting trimming reported EBITDA but not cash flow. Only one small regulatory approval remains, and management expects to clear the vote while conceding the near-term market reaction has been poor.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, DAN was trading at $23.81 on NYSE in the Manufacturing sector, with a market capitalization of approximately $2.3B. The 52-week trading range was $18.96 to $39.56. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.